Skip to main content
CME and General Info
Registration Desk Hours
Accreditation
CE/CME Evaluations
FAQs
Agenda
PAINWeek 101 Suggested Agenda
Full Schedule
Browse By Date
Poster Abstracts
Monday, September 5, 2022
Tuesday, September 6, 2022
Wednesday, September 7, 2022
Thursday, September 8, 2022
Friday, September 9, 2022
Browse By Title
Browse By Faculty
Sort by Track
Exhibit Hall
Exhibitors
Floor Plan
Sponsored Programs
Faculty
Abstracts
Need Help?
Toggle navigation
Login
Search
Home
CME and General Info
Registration Desk Hours
Accreditation
CE/CME Evaluations
FAQs
Agenda
PAINWeek 101 Suggested Agenda
Full Schedule
Browse By Date
Poster Abstracts
Monday, September 5, 2022
Tuesday, September 6, 2022
Wednesday, September 7, 2022
Thursday, September 8, 2022
Friday, September 9, 2022
Browse By Title
Browse By Faculty
Sort by Track
Exhibit Hall
Exhibitors
Floor Plan
Sponsored Programs
Faculty
Abstracts
Need Help?
Tweets by PAINWeek 2022
Icon Legend
This session is not in your agenda.
This session is in your agenda. Click to remove it
Back
Favorite
0
Like
Facebook
Tweet
Print
Manuel Merlos, PhD
Head of Pharmacology
Welab Barcelona
Barcelona, Catalonia, Spain
Presentation(s):
Poster Number-61 - ADV-484, a Novel Selective Inhibitor of alpha2delta-1 for the Treatment of Neuropathic Pain
Poster Abstracts
Poster Number-62 - ADV-502, a Novel Dual Sigma-1 Receptor Antagonist and Mu-Opioid Receptor Agonist for the Treatment of Pain: I. Discovery and Preclinical Evaluation
Poster Abstracts
Poster Number-63 - ADV-502, a Novel Dual Sigma-1 Receptor Antagonist and Mu-Opioid Receptor Agonist for the Treatment of Pain: II. Tolerance and Opioid-Induced Hyperalgesia
Poster Abstracts
Chat with us
, powered by
LiveChat